Washington state purchases three-year supply of abortion pill
Reuters
Published Apr 05, 2023 12:03AM ET
Updated Apr 05, 2023 12:45AM ET
(Reuters) - Washington state's government said on Tuesday it had purchased a three-year supply of abortion pill mifepristone as a Texas judge mulls a nationwide ban on the medication's sale.
The state's Democratic governor directed its Department of Corrections, which has a pharmacy license, to purchase the medication last month, a government statement said.
The full shipment was delivered on March 31, it added.
U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas could soon order the U.S. Food and Drug Administration to reconsider its 22-year-old approval for a pill used in the most common form of abortion in the United States, or order the approval revoked outright.
"Health care should be decided by a patient and their doctor, not a judge in Texas," Washington Governor Jay Inslee said in a tweet, adding that the purchase ensured "continued access" for all patients in his state.
Legal fights over abortion rights have ramped up in the United States after a Supreme Court ruling last year that overturned the landmark 1973 Roe v. Wade decision legalizing the procedure.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.